Objective: Oesophageal squamous cell carcinoma is one of the deadliest malignancies worldwide. Contactin-1, a neural adhesion molecule, is implicated in tumour invasion and metastasis. The purpose of this study was to investigate the expression of CNTN-1 in normal and cancerous oesophageal tissue, and the potential relevance to clinicopathological features. Methods: Thirty normal oesophageal tissue samples and 82 primary oesophageal squamous cell carcinoma tissue samples were included in this study. The expression levels of CNTN-1, VEGF-C and HIF-1a messenger RNA were determined using reverse transcriptase -polymerase chain reaction and quantitative real-time polymerase chain reaction. The expression of the CNTN-1 protein was measured using immunohistochemistry. Results: The expression of CNTN-1 messenger RNA was significantly increased in the tumour tissue compared with the normal oesophageal tissue (P ¼ 0.001). The oesophageal squamous cell carcinoma tissue consistently showed higher CNTN-1 protein levels. The CNTN-1 expression correlated with the oesophageal squamous cell carcinoma stage (P ¼ 0.006), lymph node metastasis (P ¼ 0.018) and lymphatic invasion (P ¼ 0.035). The messenger RNA level of CNTN-1 correlated significantly with those of VEGF-C and HIF-1a. Conclusions: The expression of CNTN-1 is upregulated in the oesophageal squamous cell carcinoma tissue and related to stage, lymph node metastasis and lymphatic invasion. Thus, CNTN-1 may be involved in the progression and pathogenesis of oesophageal squamous cell carcinoma.
INTRODUCTION
Oesophageal squamous cell carcinoma (ESCC), the sixth most common cause of cancer-related deaths, is associated with a dismal prognosis (1, 2) . Metastasis, the major factor governing cancer patient mortality, is a complicated process that is currently uncontrolled and presents a continuing therapeutic challenge (3) . Oesophageal carcinoma commonly metastasizes to the lymph nodes, and lymph node metastases are correlated with the prognosis of the patients (4, 5) . Molecules associated with oesophageal tumour development and metastasis are being actively investigated, with specific molecules and mechanisms found to facilitate these processes (6, 7) . Understanding the molecules responsible for human ESCC progression will contribute towards the development of its treatment.
Contactin-1 (CNTN-1) is a glycosyl phosphatidylinositol anchor neural cell adhesion molecule that belongs to the contactin subgroup of the immunoglobulin (Ig) superfamily (8) . CNTN-1 associates with other cell surface proteins and potentially participates in various signal transduction pathways and cellular functions (9) . This neural adhesion molecule is also a downstream effector of the vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 (VEGF-C/VEGFR3) signalling in cancer cells. VEGF-C induces the recruitment of CCAAT-enhancer-binding proteins (C/EBP) to the CNTN-1 promoter and activates it in lung cancer cells (10) . CNTN-1 is also involved in tumour invasion and metastasis. Knockdown of CNTN-1 resulted in extensive inhibition of lung adenocarcinoma cell metastasis and increased survival in an animal model (11) . In human lung adenocarcinoma, CNTN-1 was associated with an invasive ability and reversely correlated with the prognosis of patients (11) . Previously, we have confirmed that CNTN-1 is a downstream effector of VEGF-C pathway in ESCC and that CNTN-1 regulates oesophageal cancer cell proliferation and migration (12) . However, CNTN-1 expression between normal and cancerous oesophageal tissue and the association of clinicopathological features with CNTN-1 expression in ESCC remain unknown.
Hypoxia is commonly associated with the progression of multiple tumours including ESCC (13) . The transcription factor hypoxia-inducible factor-1 (HIF-1) is a major regulator of tissue in response to hypoxia and activates the transcription of hypoxia-inducible genes, including VEGF (14) , inducible nitric oxide synthase (15) and heme oxygenase-1 (16) . HIF-1 is a heterodimer consisting of an oxygensensitive alpha-subunit (HIF-a) and a constitutive betasubunit (HIF-b). Previous studies have shown that HIF-1a expression is associated with lymphatic metastasis in ESCC (17 -20) . Recently, it was demonstrated that HIF-1a mediates the activation of VEGF-C (21), which may then exert its effect via CNTN-1. Therefore, we hypothesized the presence of a link between HIF-1a and CNTN-1. In this manuscript, we investigated the messenger RNA (mRNA) and protein levels of CNTN-1 in normal oesophageal tissue and ESCC tissue samples. We also explored the association of CNTN-1 expression with clinicopathological factors.
PATIENTS AND METHODS

TISSUE SAMPLES
The ESCC samples were collected from 82 patients who had not received chemotherapy or radiotherapy prior to surgery between 2008 and 2010. For these patients, if preoperative ultrasonography or computed tomography (CT) does not show any enlarged cervical lymph nodes (minor axis ,0.5 cm), patients were to undergo a subtotal esophagectomy with two-field lymphadenectomy through a right thoracotomy, followed by a laparotomy. If enlarged cervical lymph nodes were shown by preoperative ultrasonography or CT, patients were to undergo radical oesophagectomy with cervico-thoraco-abdominal three-field lymphadenectomy through a right thoracotomy, followed by a laparotomy and a cervical incision. The resection extent includes nodes along the cervical part of the oesophagus, deep cervix and supraclavicule. Thirty normal oesophageal tissue samples were obtained from surgical resections of trauma patients. These tissue were obtained postoperatively in 2008 from the Gastrointestinal Center, Jiangyin People's Hospital, Medical School of University of Southeast of China (Jiangyin, China). All patients provided signed, informed consent for their tissue samples to be used for scientific research. The ethical approval for the study was obtained from the Jiangyin People's Hospital, Medical School of University of Southeast of China. All diagnoses were based on pathological and/or cytological evidence. The histological features of the specimens were evaluated by a senior pathologist according to the classification criteria from the World Health Organization (22) . Tissue samples were obtained prior to chemotherapy and radiation therapy and were immediately frozen and stored at 2808C prior to real-time polymerase chain reaction (PCR) analysis.
RNA EXTRACTION, REVERSE TRANSCRIPTASE-PCR AND REAL-TIME PCR
The total RNA from the oesophageal tissue samples was extracted with Trizol (Invitrogen, Carlsbad, CA, USA) and reverse transcribed to complementary DNA (cDNA) using an oligo(dT) 12 primer and Superscript II (Invitrogen). The SYBR green dye (Takara, Osaka, Japan) was used for the amplification of cDNA. The mRNA levels of CNTN-1, HIF-1a, VEGF-C and the internal standard glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were measured using real-time quantitative PCR in triplicate on a Prism 7500 realtime PCR machine (Applied Biosystems, Foster City, CA, USA). Primers specific for the above genes are listed in Table 1 . PCR was performed in a 20 ml reaction mixture. The thermal cycling conditions included an initial denaturation step of 958C for 20 s, followed by 40 cycles at 958C for 5 s and annealing at 608C for 30 s. The relative mRNA expression levels were normalized to GAPDH.
IMMUNOHISTOCHEMISTRY STAINING
The tissue samples were fixed in 10% neutral buffered formalin and embedded in paraffin. Three-micrometer thick paraffin sections were deparaffinized and heat-treated with citrate buffer ( pH 6.0) for 7 min as an epitope retrieval protocol. Endogenous peroxidase was blocked with 3% hydrogen peroxide for 15 min at room temperature and Jpn J Clin Oncol 2012;42 (7) 613 tissue non-specific-binding sites were blocked with skim milk powder at 4% applied for 30 min. Sections were then incubated with the CNTN-1 antibody (Santa Cruz Biotechnology) for 1 h (dilution 1:600) and mixed with skim milk powder at 2% again to reduce the non-specific staining. Biotinylated secondary antibody was then added for 30 min. Avidin -biotin -peroxidase complex (Dako LSAB2 system, DAKO Co., Carpinteria, CA, USA) was added and colour was developed using 3-3 0 -diaminobenzidine. The counterstaining was performed with haematoxylin. All steps were performed at room temperature. Negative controls consisted of tissue sections undergoing similar staining procedures in the absence of the primary antibody.
The criteria for scoring the stained sections were as follows: negative (0), ,10% of the whole tissue section stained positive; weakly positive (þ1), 10 -25% of the whole tissue section stained positive; moderately positive (þ2), 25 -75% of the whole tissue section stained positive; and strongly positive (þ3), .75% of the tissue section stained positive.
STATISTICAL ANALYSIS
The differences in the demographic characteristics between the tumour patients and non-cancer subjects were evaluated using the x 2 test. The relative mRNA expression levels were presented as box-plot graphics unless indicated otherwise. The differences between the two groups were assessed using the Mann -Whitney U-test and the data involving more than two groups were analysed using the Kruskal -Wallis test. Univariate analysis was carried out using x 2 test and multivariate analysis was carried out by the use of a logistic regression model. Correlation analysis between the CNTN-1 IHC staining score and the mRNA level was done using the Spearman r test. Correlation analysis of the mRNA expression data was performed using the Pearson test. The statistical analysis was performed using the SPSS software (Release 17.0, SPSS Inc.). The data were considered significant if P , 0.05.
RESULTS
THE OVEREXPRESSION OF CNTN-1 IN OESOPHAGEAL CANCER TISSUE
To examine the expression level of CNTN-1 mRNA between normal and cancerous human oesophageal tissue, 30 normal oesophageal tissue samples and 82 ESCC samples were collected. The demographic and histopathological features of the tissue samples are summarized in Table 2 . There was no significant difference in the age (P ¼ 0.299) and sex (P ¼ 0.371) distributions between the ESCC patients and noncancer subjects. There were a total of 115 regional lymph node metastases in the 82 ESCC patients. The transcriptional level of CNTN-1 in these tissue samples was determined using reverse transcriptase -PCR and quantitative real-time PCR analysis. As shown in Fig. 1A and B, the cancerous tissue demonstrated a significant increase in CNTN-1 mRNA expression compared with the normal oesophageal samples. To confirm the upregulation of CNTN-1 on the protein level, immunohistochemistry (IHC) staining was performed in 20 paraffin-embedded normal oesophageal tissue samples and 30 tumour tissue samples. Corresponding with the real-time PCR analysis, an overall stronger staining for CNTN-1 was frequently observed in the ESCC tissue, whereas very weak staining of CNTN-1 was observed in the normal samples ( Fig. 2A) . However, there was heterogeneity within the tumour samples. The difference in the CNTN-1 expression pattern within tumour samples may be attributed to the heterogeneity of the ESCC background. When samples were scored by a pathologist, as described in the Patients and methods section, the differences were significant (P ¼ 0.001; Fig. 2B and C) . Moreover, IHC staining scores of CNTN-1 correlated with its mRNA levels in the 30 tumour tissue samples. (r ¼ 0.522, P ¼ 0.003; Fig. 2D ). These results indicated that CNTN-1 might be involved in the pathogenesis of oesophageal cancer. Fig. 3A) . The expression of CNTN-1 was also associated with lymph node metastasis ( pN) (P ¼ 0.018, Fig. 3B ) and lymphatic invasion (P ¼ 0.035). Other clinicopathological parameters, including age, gender and differentiation, were not related to CNTN-1 expression (Table 3) .
DETERMINATION OF FACTORS AFFECTING PN
In univariate analysis by logistic regression analysis, histology, pT, stage, lymph invasion and vascular invasion were significant prognostic factors (P ¼ 0.0008, P ¼ 0.0001, P ¼ 0.0002, P ¼ 1.97 Â 10 28 , P ¼ 1.46 Â 10 25 , respectively) (Supplementary data, Table S1 ). A marginal association was also found between CNTN-1 expression and pN (P ¼ 0.0579). A multivariate analysis was performed to evaluate the independent prognostic role of CNTN-1 after adjusting for other significant covariates. All variables that significantly affected pN in the univariate analysis were introduced into a logistic regression model (Supplementary data, Table S2 ). No significant association was found between CNTN-1 expression and pN.
THE EXPRESSION OF CNTN-1 CORRELATED WITH THAT OF VEGF-C VEGF-C has angiogenic and lymphangiogenic properties and acts as the upstream regulator of CNTN-1 in ESCC cell lines (12) . To investigate the correlation between VEGF-C and CNTN-1, the mRNA level of VEGF-C was detected in 74 of the 82 (90.2%) tumour samples. A significant association was found between the VEGF-C and CNTN-1 mRNA levels (r ¼ 0.415, P ¼ 0.004; Fig. 4A ).
THE EXPRESSION OF CNTN-1 CORRELATED WITH THAT OF HIF-1a
HIF-1a is a transcription factor that regulates the transcription of genes associated with cell proliferation and vascular development. In growing tumours, hypoxia induces the expression of HIF-1a, which induces VEGF-C to form blood vessels that supply tumour cells. Thus we examined whether there was an association between HIF-1a and CNTN-1 mRNA expression in the ESCC tissue samples. The mRNA level of HIF-1a was detected in 70 of the 82 (85.4%) tumour samples. A significant association was found between HIF-1a and CNTN-1 expression (r ¼ 0.525, P , 0.0001; Fig. 4B ). Moreover, HIF-1a expression showed a marginally significant correlation with that of VEGF-C (r¼ 0.202, P ¼ 0.049; Fig. 4C) . These results indicate a link between HIF-1a, VEGF-C and CNTN-1 expression levels.
DISCUSSION
The CNTN-1 (contactin-1) gene is located at 12q11-q12 (23) . CNTN-1 is a member of the Ig superfamily with a common structure of six C2 Ig-like domains, four fibronectin type III repeats and a glycosylphosphatidylinositol anchor (24) . The expression and function of CNTN-1 has been extensively characterized in the central nervous system, suggesting a critical role of CNTN-1 in the regulation of neurite growth, synapse formation, fasciculation and myelin organization (25 -28) . Recently, CNTN-1, a neural adhesion molecule, has been recognized to play a role in cancer cells. CNTN-1 was first identified as a downstream effector of the VEGF-C/VEGFR3 pathway in lung and oesophageal cancers. Exogenous VEGF-C increases the transcription of CNTN-1 by recruitment of the transcription factor C/EBP (10, 12) . A recent report demonstrated that the lentivirusmediated short hairpin (sh) RNA targeting of VEGFR-3 inhibits proliferation and induces apoptosis in the MKN45 gastric cancer cells via downregulation of CNTN-1 (29) . CNTN-1 is also essential for the invasion and metastasis of human lung adenocarcinoma via the activation of Ras homolog gene family, member A (RhoA) (11) . In a metastatic murine tumour model, silencing of CNTN-1 resulted in the suppression of tumour metastasis and an increase in survival. Moreover, patients with high-expressing CNTN-1 tumours had an advanced disease stage, pN and poor survival, relative to patients with low-expressing CNTN-1 tumours (11) . Deregulation of CNTN-1 mRNA was also found in endometrial adenocarcinoma (EAC). CNTN-1 has higher expression in late-stage than in early-stage EAC (30) .
In this study, using real-time PCR analysis and IHC, we found that the CNTN-1 mRNA and protein levels were upregulated in the ESCC tissues, indicating the involvement of CNTN-1 in oesophageal oncogenesis and tumour development. In addition, CNTN-1 expression levels significantly correlated with the ESCC stage, pN and lymphatic invasion. Thus, CNTN-1 expression may have prognostic potential, as lymphatic invasion is a good predictor of pN in patients with ESCC (4). This correlation reinforces our results from oesophageal cancer-derived Eca-109 and TE-1 cells demonstrating that CNTN-1 expression is associated with cell migration (12) . Our study illustrates the clinicopathological significance of CNTN-1 in oesophageal cancer. Therefore, inhibitors towards CNTN-1 may be a possible target for the therapy of ESCC. 
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Overexpression of CNTN-1 in ESCCs
VEGF-C is a key regulator of lymphangiogenesis; however, it is capable of inducing angiogenesis (31) . VEGF-C expression correlates with tumour lymphangiogenesis and pN in various types of human cancers including ESCC (32) . We have previously demonstrated that the expression of VEGF-C correlated with CNTN-1 in 38 pairs of ESCC tissues (12) . In this study, using a larger tumour sample size and normal oesophageal tissues, we confirmed the significant correlation between the VEGF-C mRNA level and CNTN-1.
The adaptation to hypoxia, a universal hallmark of carcinomas, is a critical step for tumour cell survival and growth. Recent studies indicate a possible role of HIF-1a in tumour lymphangiogenesis by regulating VEGF-C in cancer cells. The secreted VEGF-C concentration was increased significantly under hypoxia in MCF7 and A549 tumour cells compared with the normoxic condition (33) . The expression of HIF-1a correlates with VEGF-C expression in breast cancer and oral squamous cell carcinoma (34, 35) . In this present study, we demonstrated that the transcription level of CNTN-1 correlated with that of HIF-1a, suggesting a possible role for CNTN-1 under hypoxia.
CONCLUSIONS
In summary, CNTN-1 is overexpressed in the ESCC samples compared with the normal oesophageal tissue. CNTN-1 mRNA correlated with the tumour stage, pN and lymphatic invasion. The expression of CNTN-1 correlated with that of VEGF-C and HIF-1a in the ESCC tissues. These findings suggest that CNTN-1 plays a role in the tumour progression in human ESCC.
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